Elon Musk's Neuralink gets FDA approval for study of brain implants in humans

Elon Musk's brain-implant company Neuralink said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study

Updated - May 26, 2023 01:24 pm IST

Published - May 26, 2023 11:50 am IST

File photo of the Neuralink logo and Elon Musk

File photo of the Neuralink logo and Elon Musk | Photo Credit: REUTERS

Elon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.

On at least four occasions since 2019, Musk has predicted that his medical device company would soon start human trials of a brain implant to treat intractable conditions such as paralysis and blindness.

Yet the company, founded in 2016, did not seek permission from the FDA until early 2022 - and the agency rejected the application, seven current and former employees told Reuters in March.

The FDA approval comes as U.S. lawmakers urged regulators earlier this month to investigate whether the make-up of a panel overseeing animal testing at Neuralink contributed to botched and rushed experiments. Neuralink has already been the subject of federal probes.

(For top technology news of the day, subscribe to our tech newsletter Today’s Cache)

Reuters reported on December 5 that the USDA's Inspector General was investigating, at the request of a federal prosecutor, potential violations of the Animal Welfare Act, which governs how researchers treat and test certain types of animals.

The probe has also been looking at the USDA's oversight of Neuralink.

In a tweet on Thursday, Neuralink said that the company is not yet open for a clinical trial.

"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink said in a tweet on Thursday.

Neuralink is developing a brain implant it hopes will help paralysed people walk again and cure other neurological ailments.

The FDA did not immediately respond to a Reuters request for comment.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.